The town planning department on Tuesday signed a contract for the demolition of two apartment buildings in the government housing settlement of Platy in Aglandja, Nicosia, as part of the government’s Ktizo plan, which aims atimproving living conditions in refugee estates. According to a statement released by the interior ministry, the agreed cost for the […]

Construction company Aktor (formerly Intrakat) is now seeking over €35 million in damages through the courts after the public works department terminated the contract with regarding the Paphos-Polis road project, according to its CEO Alexandros Exarchou, who spoke at an online press conference. “We are compelled to pursue our legal rights in Cyprus and, if […]

The Paphos-Polis highway is the fourth public project this government has terminated because of major disputes with the contractor. Last year it pulled the plug on the waste treatment plant in Pentakomo, while earlier this year it ended the contract for the Larnaca port and marina with Kition Ocean Holdings followed by the termination of […]

This study finds contract farming in Lao PDR to be effective in raising incomes of small farmers, thus reducing poverty.

Outgoing firm Principal Service Solutions says incoming staffing agency Manpower may bring the workers back.

Nick Guerin, CSP, director of environmental, health & safety at Tessy Plastics highlights how contract manufacturers are driving sustainability in the medical plastics industry.

This week, I’m rerunning some popular posts while we put the finishing touches on DCI’s new 2024-25 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors.

Click here to see the original post from June 2024.

---

The 340B contract pharmacy market shows little sign of slowing down. Drug Channels Institute’s exclusive analysis of the 2024 market reveals that:Read more »

Informa Connect’s PBM Contracting Summit
December 10-11, 2024 | Chicago, IL
Drug Channels readers save 10% with code 24DRCH10*

Experts from across the US come together each year at the PBM Contracting Summit to gain innovative and practical contracting strategies, master PBM innovation and design, improve patient care management and rising costs, understand the current legislative issues impacting contract negotiations and more. Join us in Chicago (or virtually) where you’ll benefit from two days of learning, education and networking, and will return to the office having mastered the complex PBM landscape.

You’ll hear from Matthew Gibbs, Pharm.D., Pharmacy Transformation Leader of Blue Shield of California as he leads a comprehensive discussion on the PBM landscape over the last year, and delves into the evolving trends and emerging challenges shaping the current industry today.

Other expert and thought leaders from within the industry are slated to present deep dive sessions, workshops and panels that will answer your most pressing questions:

• What are the latest legislative updates and proposed federal bills impacting PBM operations?
• What's on the horizon for alternative PBMs? What are the top intricacies of rebate eligibility? What are the market impacts of innovative models such as Mark Cuban's Cost Plus Drugs and Amazon's pharmacy model?
• What can be learned from the J&J lawsuit? Review the expansion of data access and the importance of employer's fiduciary duties.
• What are the challenges of vertical integration?
• How do PBMs manage their contracting processes with plan sponsors to create successful contracts?
• What are the most effective strategies for spread pricing and reimbursement models?
• What is the best solution to navigate the challenges of the 340B drug pricing program and PBM contracting?
• What is the best way to design and optimize benefits for covering GLP-1s?
• How can I ensure compliance with ERISA requirements?
• What are the latest developments in copay maximizer and accumulator programs?
• What market dynamics and barriers are impacting pricing and demand?
• What can be learned from the economic landscape of biosimilars and specialty therapeutics?
• And much more!

View the agenda for the PBM Contracting Summit to see the complete picture – the program, speakers, and more, visit www.informaconnect.com/pbm-contracting for further details and to register. Drug Channels readers will save 10% off when they use code 24DRCH10 and register prior to November 8, 2024.*

*Cannot be combined with other offers or used towards a current registration. Cannot be combined with special category rates or other offers. Other restrictions may apply.

---

The content of Sponsored Posts does not necessarily reflect the views of HMP Omnimedia, LLC, Drug Channels Institute, its parent company, or any of its employees. To find out how you can promote an event on Drug Channels, please contact Paula Fein (paula@DrugChannels.net).

Venture creation in biotech is witnessing a sustained contraction. After the pandemic bubble’s over-indulgence, the venture ecosystem appears to have reset its pace of launching new startups. According to the latest Pitchbook data, venture creation in biotech hit its slowest

The post The Biotech Startup Contraction Continues… And That’s A Good Thing appeared first on LifeSciVC.

Pharmaceutical and biotech companies breathed a sigh of relief Monday when the Federal Circuit unanimously ruled in a precedential opinion that the mere sale of manufacturing services to create embodiments of a patented product is not a “commercial sale” of the invention that triggers the on-sale bar of 35 U.S.C. § 102(b) (pre-AIA).[1]  The en banc opinion...… Continue Reading

Cogdell Spencer ERDMAN(SM) Announces New Contract in the Northwest Region

Karnataka government's alleged Muslim reservation proposal sparks controversy ahead of bypolls, but Chief Minister's Office denies the reports entirely.

Total staff count up 2.74%, but still lower than pre-Covid levels

The shares of Cyient DLM Limited were trading at ₹644.85 up by ₹11.80 or 1.86 per cent on the NSE today at 1.40 pm

GM Joe Schoen said that the injury guarantee in Daniel Jones' contract will not influence the Giants' decision about whether they bench their starting quarterback.

Cornerback Deommodore Lenoir and the San Francisco 49ers reportedly have agreed to a five-year contract extension worth $92 million.

Cornerback Deommodore Lenoir and the San Francisco 49ers have agreed to a five-year contract extension, a source told NBC Sports Bay Area's Matt Maiocco.

On November 5, the stock price and all derivatives contracts on Coal India will be adjusted for dividend appropriately

Three bidders were strategically placed to ensure that MCK Kutty Engineering Projects bagged the contract, says Opposition

Marketline

The Middle East, led by Qatar, was the primary exporter, while Asian countries, notably India and China, were key importers